BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang S, Huang X, Ni L, Xia R, Nakayama K, Chen S. Positive consequences of splenectomy for patients with schistosomiasis-induced variceal bleeding. Surg Endosc 2021;35:2339-46. [PMID: 32440930 DOI: 10.1007/s00464-020-07648-8] [Reference Citation Analysis]
2 Fang H, Yu L, You D, Peng N, Guo W, Wang J, Zhang X. In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis. Front Bioeng Biotechnol 2020;8:613784. [PMID: 33553120 DOI: 10.3389/fbioe.2020.613784] [Reference Citation Analysis]
3 Tamarozzi F, Fittipaldo VA, Orth HM, Richter J, Buonfrate D, Riccardi N, Gobbi FG. Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature. PLoS Negl Trop Dis 2021;15:e0009191. [PMID: 33764979 DOI: 10.1371/journal.pntd.0009191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liu J, Meng J, Zhou C, Shi Q, Yang C, Ma J, Chen M, Xiong B. A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination. J Interv Med 2021;4:32-8. [PMID: 34805945 DOI: 10.1016/j.jimed.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS Negl Trop Dis 2021;15:e0010065. [PMID: 34932562 DOI: 10.1371/journal.pntd.0010065] [Reference Citation Analysis]
6 Santo MCCDE, Gryschek RCB, Farias AQ, Andraus W, Carvalho NB, Leite OHM, Castro FC, Cerri GG, Hypólitti GH, Carnevale FC, Assis AM. Management and treatment of decompensated hepatic fibrosis and severe refractory Schistosoma mansoni ascites with transjugular intrahepatic portosystemic shunt. Rev Inst Med Trop Sao Paulo 2022;64:e26. [PMID: 35384957 DOI: 10.1590/S1678-9946202264026] [Reference Citation Analysis]
7 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]